Physical activity program
Other- 30 second chair test,
- balance with joint-feet and semi-tandem stance
- 4 meters comfortable walking test were evaluated
NCT Number: NCT04647682
Our hypothesis was that physical activity program will be acceptable and may counteract physical and mental decline among older adults hospitalized in COVID-19 unit
Looking for future studies?
Notify Me75 year and older
All sexes
Observational
CHU de Grenoble, Grenoble, France
The 30 second chair test, balance with joint-feet and semi-tandem stance, and 4 meters comfortable walking test were evaluated. Depending on their score, a specific physical activity (PA) program was selected and explained. The program was printed, explained and left in the room. This intervention included 5 different PA programs.
Final evaluation (one day before leaving the unit) recording physical performance (same physical tests used for inclusion evaluation), Hospital Anxiety and depression (HAD) score, Activities Daily Living (ADL) and self-satisfaction of the program.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through study completion, an average of 15 days
adherence of the intervention evaluated by the number of completed exercise days compared to the number of total intervention days
Time frame: through study completion, an average of 15 days
Comparison between inclusion and final physical performances measured by the 30-second chair test, balance with joint-feet, semi-tandem stance, 4 meters comfortable walking test, functional abilities with the evaluation of ADL score and HAD scores.
University Hospital, Toulouse
Other
Feasibility and Effect of Implementing Physical Activity Program Implementation During COVID-19 in Hospitalized Positive COVID-19 Older Adults
Acronym: Cov-activity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07552779
COVID-19, COVID-19 (Coronavirus Disease 2019)
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT06194357
Behavior, COVID-19
Hong Kong
View Trial DetailsNCT04639466
COVID-19, COVID-19 Infection
Claremont, California, United States
View Trial DetailsNCT04355533
COVID-19, COVID-19 Infection
Paris, France
View Trial Details